ATM and cancer: ATM and its downstream molecule Chk2 are the primary kinases responsible for G1/S phase arrest of the cell cycle33,34, and S-phase-specific DNA damage has been reported to activate the immune response including induction of CXCL9, -10 expression in cancer cells26,27.